Literature DB >> 14595756

Alterations of chromosomal copy number during progression of diffuse-type gastric carcinomas: metaphase- and array-based comparative genomic hybridization analyses of multiple samples from individual tumours.

Dun-Fa Peng1, Hiroyuki Sugihara, Ken-ichi Mukaisho, Yasuhiro Tsubosa, Takanori Hattori.   

Abstract

The application of comparative genomic hybridization (CGH) has led to the rapid accumulation of cytogenetic information on gastric carcinoma (GC), but there is little information on the time sequence of cytogenetic changes. In the present study, degenerate oligonucleotide-primed polymerase chain reaction (DOP-PCR) and CGH were applied to multiple samples microdissected from 19 diffuse-type GCs including eight early cancers. Recurrent gains were detected at 8q, 3q, 7q, and 8p, and loss at 17p (in more than 50% of the cancers), the frequencies of which were fairly similar between the samples with (SIG) and those without (POR) abundant signet ring cells. Earlier stemline changes (8q+, 8p+, 1q+, 17p-, etc), with breakpoints that were common to all the samples, were discriminated from later sideline changes (2q+, 11q+, 17q-, 21q-, etc) in individual tumours. The changes were generally common to early and advanced cancers, except for 7p+, 15q+, 3p-, and 18q-, which were largely sideline changes and more frequently detected in advanced cancers (p<0.05). Because the samples with 7p+ had a greater number of copy-number changes than those without 7p+ (p<0.01), 7p+ may play a role in tumour progression by acceleration of chromosomal instability. Fifteen different chromosomal loci with amplification were detected in ten cases, mostly as sideline changes in advanced cancers. By microarray-based CGH, KRAS, MDM2, and FGFR2 were confirmed in the amplicons at 12p, 12q, and 10q, and FES at 15q26, for the first time in GC. These results support the notion that SIG and POR are of a genetically single lineage in both early and advanced diffuse-type GC and that the majority of advanced cancers derive from early cancers through the accumulation of various sideline changes in addition to stemline changes. Copyright 2003 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14595756     DOI: 10.1002/path.1459

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  24 in total

1.  Expression of Cdx2 in early GRCL of Barrett's esophagus induced in rats by duodenal reflux.

Authors:  Takeshi Tatsuta; Ken-Ichi Mukaisho; Hiroyuki Sugihara; Koichi Miwa; Tohru Tani; Takanori Hattori
Journal:  Dig Dis Sci       Date:  2005-03       Impact factor: 3.199

2.  [Spindle-cell osteosclerotic bone lesion with MDM2 amplification].

Authors:  C Mogler; M Boxberg; C Knebel; W Weichert; K Wörtler; K Specht
Journal:  Pathologe       Date:  2018-03       Impact factor: 1.011

3.  Value of FGFR2 expression for advanced gastric cancer patients receiving pazopanib plus CapeOX (capecitabine and oxaliplatin).

Authors:  Seung Tae Kim; Soomin Ahn; Jeeyun Lee; Su Jin Lee; Se Hoon Park; Young Suk Park; Ho Yeong Lim; Won Ki Kang; Kyoung-Mee Kim; Joon Oh Park
Journal:  J Cancer Res Clin Oncol       Date:  2016-03-16       Impact factor: 4.553

4.  Array-based comparative genomic hybridization from formalin-fixed, paraffin-embedded breast tumors.

Authors:  Sandy Devries; Sarah Nyante; Jim Korkola; Richard Segraves; Kentaro Nakao; Dan Moore; Hanik Bae; Monica Wilhelm; Shelley Hwang; Frederic Waldman
Journal:  J Mol Diagn       Date:  2005-02       Impact factor: 5.568

5.  Gastric and intestinal phenotypic cell marker expressions in gastric differentiated-type carcinomas: association with E-cadherin expression and chromosomal changes.

Authors:  Koji Morohara; Yusuke Tajima; Kentaro Nakao; Nobukazu Nishino; Shigeo Aoki; Masanori Kato; Masaaki Sakamoto; Kimiyasu Yamazaki; Tsutomu Kaetsu; Satoshi Suzuki; Akira Tsunoda; Tetsuhiko Tachikawa; Mitsuo Kusano
Journal:  J Cancer Res Clin Oncol       Date:  2006-01-31       Impact factor: 4.553

6.  Genetic alterations in primary gastric carcinomas correlated with clinicopathological variables by array comparative genomic hybridization.

Authors:  Ji Un Kang; Jason Jongho Kang; Kye Chul Kwon; Jong Woo Park; Tae Eun Jeong; Seung Mu Noh; Sun Hoe Koo
Journal:  J Korean Med Sci       Date:  2006-08       Impact factor: 2.153

7.  Lineage analysis of early and advanced tubular adenocarcinomas of the stomach: continuous or discontinuous?

Authors:  Takahisa Nakayama; Zhi-Qiang Ling; Ken-ichi Mukaisho; Takanori Hattori; Hiroyuki Sugihara
Journal:  BMC Cancer       Date:  2010-06-21       Impact factor: 4.430

8.  Application of a novel method of double APAAP staining with subsequent quantitative image analysis to the examination of integrin expression in undifferentiated-type gastric carcinomas.

Authors:  Natalia Yanchenko; Hiroyuki Sugihara; Takanori Hattori
Journal:  J Histochem Cytochem       Date:  2009-08-17       Impact factor: 2.479

9.  A short guide to hereditary diffuse gastric cancer.

Authors:  Parry Guilford; Vanessa Blair; Helen More; Bostjan Humar
Journal:  Hered Cancer Clin Pract       Date:  2007-12-15       Impact factor: 2.857

10.  A novel method, digital genome scanning detects KRAS gene amplification in gastric cancers: involvement of overexpressed wild-type KRAS in downstream signaling and cancer cell growth.

Authors:  Hiroaki Mita; Minoru Toyota; Fumio Aoki; Hirofumi Akashi; Reo Maruyama; Yasushi Sasaki; Hiromu Suzuki; Masashi Idogawa; Lisa Kashima; Kazuyoshi Yanagihara; Masahiro Fujita; Masao Hosokawa; Masanobu Kusano; Sorin Vasile Sabau; Haruyuki Tatsumi; Kohzoh Imai; Yasuhisa Shinomura; Takashi Tokino
Journal:  BMC Cancer       Date:  2009-06-23       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.